Last reviewed · How we verify
NCT04503421
Use of Blood Flow Restriction (BFR) Therapy in Post-operative Rehabilitation Following Distal Biceps Tendon Repair
NA trial testing Blood Flow Restriction Therapy in Bicep Tendon Rupture in 64 participants. Completed in 15 September 2021.
15 August 2021
Quick facts
| Lead sponsor | Henry Ford Health System |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 64 |
| Start date | 15 August 2020 |
| Primary completion | 15 August 2021 |
| Estimated completion | 15 September 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Blood Flow Restriction Therapy
Conditions studied
- Bicep Tendon Rupture — all drugs for Bicep Tendon Rupture →
Sponsor
Henry Ford Health System — full company profile →
Who can join
Adults 18 to 80, any sex, with Bicep Tendon Rupture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this investigation is to determine if using BFR during postoperative therapy would lead to increased and expedited strength gains. Additionally, the investigators would like to determine if BFR is beneficial in preventing muscle atrophy and fatty infiltration in the setting of bicep tendon tears, due to the altered tension-length relationship following surgery. The study will also look at patient reported outcomes metrics and pain scores to determine if BFR has a significant impact on the patient experience surrounding distal biceps tear and surgical repair
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04503421
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood Flow Restriction Therapy
Trials testing the same drug.
- NCT06788327 — Blood Flow Restriction Versus Standard Exercise After Rotator Cuff Repair · NA · not yet recruiting
- NCT04528992 — Effects of Blood Flow Restriction (BFR) Therapy on ACL Graft Maturation · NA · withdrawn
- NCT06324487 — A New Application in Subacromial Impingement Syndrome · NA · unknown
- NCT05596162 — The Effect of Low-Intensity Blood Flow Restriction Therapy on the Management of Acute Ankle Sprains · NA · withdrawn
- NCT06342063 — The Effects of Preoperative Blood Flow Restriction Training in Patients Undergoing ACL Reconstruction · NA · completed
Other Henry Ford Health System trials
Trials by the same sponsor.
- NCT07450183 — Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1 · Phase 2 · not yet recruiting
- NCT07418853 — Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries · NA · not yet recruiting
- NCT06670287 — The Use of Multiple Sensors to Track Sleep in Nightshift Workers · NA · recruiting
- NCT07363525 — Michigan Initial Experience Using Tigertriever for Thrombectomy · not yet recruiting
- NCT07530172 — Radioembolization Versus External Radiation Therapy · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04503421 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Henry Ford Health System
- Last refreshed: 8 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04503421.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing